Reducing adverse drug events in the outpatient chemotherapy setting
نویسندگان
چکیده
منابع مشابه
Pediatric adverse drug events in the outpatient setting: an 11-year national analysis.
OBJECTIVE Adverse drug events (ADEs) are a common complication of medical care, but few pediatric data are available describing the frequency or epidemiology of these events. We estimated the national incidence of pediatric ADEs requiring medical treatment, described the pediatric population seeking care for ADEs, and characterized the events in terms of patient symptoms and medications implica...
متن کاملAdverse drug events in the outpatient setting: an 11-year national analysis.
PURPOSE Adverse drug events (ADEs) are a common complication of medical care resulting in high morbidity and medical expenditure. Population level estimates of outpatient ADEs are limited. Our objective was to provide national estimates and characterizations of outpatient ADEs and determine risk factors associated with these events. METHODS Data are from the National Center for Health Statist...
متن کاملIdentification of Adverse Drug Events in the Outpatient Setting Using a Computerized, Text-Searching Monitor
Few studies have examined adverse drug events (ADEs) in outpatient care, and identification of these events is difficult. We are using a computerized text-searching ADE monitor to assess rates of outpatient ADEs. The monitor searches notes in the outpatient electronic medical record for drug-symptom combinations that signal possible ADEs. We collected 6 months of data from outpatient sites in B...
متن کاملReducing the risk of adverse drug events in older adults.
Adverse drug events occur in 15 percent or more of older patients presenting to offices, hospitals, and extended care facilities. These events are potentially preventable up to 50 percent of the time. Common serious manifestations include falls, orthostatic hypotension, heart failure, and delirium. The most common causes of death are gastrointestinal or intracranial bleeding and renal failure. ...
متن کاملPharmacogenomics and reducing the frequency of adverse drug events.
Drug toxicity and adverse drug events Pharmacogenomics, as applied to medical practice, offers the promise of reduction in adverse drug events (ADEs), enhanced drug efficacy and selection of patients able to respond to specific agents. This editorial will focus on the history and evolving role of pharmacogenetics and pharmacogenomics as it moves from the basic research laboratory into clinical ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2005
ISSN: 0008-543X,1097-0142
DOI: 10.1002/cncr.21445